Patent Assignment
Reel/Frame 051403/0954
Security Interest
Recorded: 2019-12-23
Pages: 15
Assignors
ACORDA THERAPEUTICS, INC.
Executed: 2019-12-23
CIVITAS THERAPEUTICS, INC.
Executed: 2019-12-23
Assignee
WILMINGTON TRUST, NATIONAL ASSOCIATION
1100 N MARKET STREET, WILMINGTON, DELAWARE, 19890
Covered Properties
(39)
Sustained Release Aminopyridine Composition
Method of Using Sustained Release Aminopyridine Compositions
Sustained Release Aminopyridine Composition
Application:
12/626,085 →
Publication:
US 2010/0272796
Sustained Release Aminopyridine Composition
Methods of Using Sustained Release Aminopyridine Compositions
Capsules Containing High Doses of Levodopa for Pulmonary Use
Patent:
8,545,878 →
Application:
13/679,245 →
Capsules Containing High Doses of Levodopa for Pulmonary Use
Patent:
8,685,442 →
Application:
13/945,160 →
Capsules Containing High Doses of Levodopa for Pulmonary Use
Capsules Containing High Doses of Levodopa for Pulmonary Use
Methods for Reducing Inter-Patient Variability of Levodopa Plasma Concentrations
Methods for Providing Rapid Relief of Motor Fluctuations in a Parkinson's Disease Patient
Application:
14/691,793 →
Publication:
US 2015/0328175
Dosator Apparatus for Filling a Capsule with Dry Powder
Ultra Low Density Pulmonary Powders
Dosator Apparatus for Filling a Capsule with Dry Powder
Sustained Release Aminopyridine Composition
Methods of Using Sustained Release Aminopyridine Compositions
Rapid Relief of Motor Fluctuations in Parkinson's Disease
Application:
15/500,608 →
Publication:
US 2017/0296498
Sustained Release Compositions of 4-Aminopyridine
Application:
15/764,160 →
Publication:
US 2018/0344649
Method, Apparatus and Software for Identifying Responders in a Clinical Environment
Application:
15/996,338 →
Publication:
US 2018/0277256
Methods for Treating an Impairment in Gait and/or Balance in Patients with Multiple Sclerosis Using an Aminopyridine
Application:
16/240,686 →
Publication:
US 2019/0134016
Durable Treatment with 4-Aminopyridine in Patients with Demyelination
Application:
16/393,586 →
Publication:
US 2019/0247378
Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions
Application:
16/395,495 →
Publication:
US 2019/0247379
Sustained Release Aminopyridine Composition
Application:
16/413,320 →
Methods of Using Sustained Release Aminopyridine Compositions
Application:
16/453,639 →
Publication:
US 2019/0314350
Sustained Release Compositions of 4-Aminopyridine
Application:
16/500,944 →
Publication:
US 2020/0108016
Methods for Treating an Impairment in Gait and/or Balance in Patients with Multiple Sclerosis Using an Aminopyridine
Application:
16/555,732 →
Publication:
US 2019/0381021
Use of 4-Aminopyridine to Improve Neuro-Cognitive and/or Neuro-Psychiatric Impairment in Patients with Demyelinating and Other Nervous System Conditions
Application:
16/705,711 →
Publication:
US 2020/0113882
Durable Treatment with 4-Aminopyridine in Patients with Demyelination
Application:
16/706,573 →
Publication:
US 2020/0113883
Indicator for an Inhaler
Patent:
752,204 →
Application:
29/484,448 →
Indicator for an Inhaler
Patent:
755,367 →
Application:
29/484,449 →
Inhaler Grip
Patent:
752,734 →
Application:
29/484,451 →
Fast Onset and Extended Duration of Inhaled Levodopa
Application:
61/716,740 →
Methods for Reducing Inter-Patient Variability of Levodopa Plasma Concentrations
Application:
61/716,753 →
Capsules Containing High Doses of Levodopa for Pulmonary Use
Application:
61/724,781 →
Civitas Therapeutics Announces Positive Phase 2 Clinical Results for CVT-301, an Inhaled L-dopa for Parkinson's Disease
Application:
61/813,605 →
Precise Dose Needed for Turning a Patient On
Application:
61/813,725 →
Dosator Apparatus for Filling a Capsule with Dry Powder
Application:
61/884,315 →
Capsules Containing High Doses of Levodopa for Pulmonary Use
Application:
61/884,319 →
Ultra Low Density Pulmonary Powders
Application:
61/884,436 →
Related Assignments
(21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 27, 2005
From: BLIGHT, ANDREW R; MARINUCCI, LAWRENCE; COHEN, RON
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 016072/0063 →
Assignment of Assignor's Interest
Nov 23, 2010
From: COHEN, RON
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 025308/0717 →
Assignment of Assignor's Interest
Jun 20, 2011
From: MYERS, MICHAEL; CUNNINGHAM, SEAN; MULLIGAN, SEAMUS
To: ELAN PHARMA INTERNATIONAL LIMITED
Reel/Frame 026480/0206 →
Patent Security Agreement (Second Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0245 →
Patent Security Agreement (First Lien)
Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0186 →
Asset Transfer Agreement
Aug 9, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 028757/0583 →
Notice of Change in Registered Office Address
Aug 9, 2012
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 028757/0817 →
Notice of Change in Registered Office Address
Aug 9, 2012
From: EDT PHARMA HOLDINGS
To: EDT PHARMA HOLDINGS
Reel/Frame 028757/0644 →
Change of Name
Aug 9, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 028757/0763 →
Release by Secured Party (Second Lien)
Oct 12, 2012
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
Reel/Frame 029116/0379 →
Assignment of Assignor's Interest
Jun 27, 2013
From: KEE, KEVIN; PENACHIO, ERNEST D.; KAMERKAR, ABHIJIT; LIPP, MICHAEL M.
To: CIVITAS THERAPEUTICS, INC.
Reel/Frame 030700/0711 →
Assignment of Assignor's Interest
Oct 16, 2015
From: BATYCKY, RICHARD P.; LIPP, MICHAEL M.; FREED, MARTIN
To: CIVITAS THERAPEUTICS, INC.
Reel/Frame 036809/0487 →
Assignment of Assignor's Interest
Nov 30, 2015
From: PENACHIO, ERNEST D.; LAVIGNE, KYLE
To: CIVITAS THERAPEUTICS, INC.
Reel/Frame 037165/0053 →
Assignment of Assignor's Interest
Nov 30, 2015
From: LIPP, MICHAEL M.; BATYCKY, RICHARD P.
To: CIVITAS THERAPEUTICS, INC.
Reel/Frame 037165/0089 →
Assignment of Assignor's Interest
Feb 12, 2016
From: BATYCKY, RICHARD P.; FREED, MARTIN
To: CIVITAS THERAPEUTICS, INC.
Reel/Frame 037726/0308 →
Security Interest
Jun 10, 2016
From: ACORDA THERAPEUTICS, INC.; CIVITAS THERAPEUTICS, INC.; NEURONEX, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 038950/0436 →
Release of Security Interest
May 31, 2017
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NEURONEX, INC.; CIVITAS THERAPEUTICS, INC.; ACORDA THERAPEUTICS, INC.
Reel/Frame 042643/0878 →
Assignment of Assignor's Interest
Jul 30, 2020
From: COHEN, RON; BLIGHT, ANDREW R.; MARINUCCI, LAWRENCE
To: ACORDA THERAPEUTICS, INC.
Reel/Frame 053357/0068 →
Release of Patent Security Agreement (First Lien)
Dec 24, 2024
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 069771/0548 →
Nunc Pro Tunc Assignment
Jan 6, 2025
From: CIVITAS THERAPEUTICS, INC.
To: MERZ PHARMACEUTICALS, LLC
Reel/Frame 069752/0843 →
Nunc Pro Tunc Assignment
Jan 6, 2025
From: ACORDA THERAPEUTICS, INC.
To: MERZ PHARMACEUTICALS, LLC
Reel/Frame 069753/0558 →